It will be intriguing to see if TNF-α strategies such as S-NGR-TNF can restore TIL trafficking, enhance ICI therapy, and augment chemotherapy delivery to EGFRm NSCLC tumors. Here, RTN4R is linked to non-small cell lung carcinoma.